These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 31169324)

  • 1. Susceptibility to adverse drug reactions.
    Ferner R; Aronson J
    Br J Clin Pharmacol; 2019 Oct; 85(10):2205-2212. PubMed ID: 31169324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harms from medicines: inevitable, in error or intentional.
    Ferner RE
    Br J Clin Pharmacol; 2014 Mar; 77(3):403-9. PubMed ID: 23683079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The law of mass action and the pharmacological concentration-effect curve: resolving the paradox of apparently non-dose-related adverse drug reactions.
    Aronson JK; Ferner RE
    Br J Clin Pharmacol; 2016 Jan; 81(1):56-61. PubMed ID: 26119837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic basis of adverse drug reactions: the perils of inappropriate dose schedules.
    Shah RR
    Expert Opin Drug Saf; 2005 Jan; 4(1):103-28. PubMed ID: 15709902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacokinetics: current requirements and future perspectives from a regulatory point of view.
    Shah RR
    Xenobiotica; 1993 Nov; 23(11):1159-93. PubMed ID: 8310705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ways to minimize adverse drug reactions. Individualized doses and common sense are key.
    Cohen JS
    Postgrad Med; 1999 Sep; 106(3):163-8, 171-2. PubMed ID: 10494273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safe use of medication in patients with cirrhosis: pharmacokinetic and pharmacodynamic considerations.
    Weersink RA; Burger DM; Hayward KL; Taxis K; Drenth JPH; Borgsteede SD
    Expert Opin Drug Metab Toxicol; 2020 Jan; 16(1):45-57. PubMed ID: 31810397
    [No Abstract]   [Full Text] [Related]  

  • 10. Adverse Drug Reactions: Type A (Intrinsic) or Type B (Idiosyncratic).
    Iasella CJ; Johnson HJ; Dunn MA
    Clin Liver Dis; 2017 Feb; 21(1):73-87. PubMed ID: 27842776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variations of pharmacokinetics of drugs in patients with cirrhosis.
    Pena MA; Horga JF; Zapater P
    Expert Rev Clin Pharmacol; 2016; 9(3):441-58. PubMed ID: 26696448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spotlight Commentary: Medicines use during pregnancy and harmful effects on offspring.
    Wei L; Cohen A
    Br J Clin Pharmacol; 2019 Jul; 85(7):1393. PubMed ID: 31020702
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetic drug-drug interactions in the intensive care unit - single-centre experience and literature review.
    Łój P; Olender A; Ślęzak W; Krzych ŁJ
    Anaesthesiol Intensive Ther; 2017; 49(4):259-267. PubMed ID: 29027654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detecting medication errors in the New Zealand pharmacovigilance database: a retrospective analysis.
    Kunac DL; Tatley MV
    Drug Saf; 2011 Jan; 34(1):59-71. PubMed ID: 21142271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doses Evaluated in Clinical Pharmacology Studies Investigating the Effect of Intrinsic and Extrinsic Factors on PK and Safety: Case Examples from Approved Drug Development Programs.
    Kaspera R; Shitara Y
    AAPS J; 2024 Jun; 26(4):71. PubMed ID: 38886275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of fasting on drug metabolism.
    Lammers LA; Achterbergh R; Mathôt RAA; Romijn JA
    Expert Opin Drug Metab Toxicol; 2020 Jan; 16(1):79-85. PubMed ID: 31851534
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetically determined adverse drug reactions involving metabolism.
    Lennard MS
    Drug Saf; 1993 Jul; 9(1):60-77. PubMed ID: 8347292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translating the dose response into risk and benefit.
    Warren JB
    Br J Clin Pharmacol; 2019 Oct; 85(10):2187-2193. PubMed ID: 30945324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial: Recent Advances in Developmental Drug Disposition.
    Collier AC
    Drug Metab Lett; 2015; 9(2):64. PubMed ID: 26517862
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug metabolism and metabolite safety assessment in drug discovery and development.
    He C; Wan H
    Expert Opin Drug Metab Toxicol; 2018 Oct; 14(10):1071-1085. PubMed ID: 30215280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.